semaglutide glp-1 ozempic in dana point is first drug FDA-approved for kidney disease An Advanced Guide to Semaglutide

Baseline cohort characteristics and treatment effects on initiation of semaglutide 0.5 mg and 1 mg, dulaglutide 1.5 mg and sitagliptin 100 mg were based on the once-weekly semaglutide clinical trial program (SUSTAIN 7 and 2)

Genetic testing that reveals peptide pathway predispositions can provide context for selecting between compounded or branded options tailored to individual biology

Full guide with UK guidance.

A large-scale study suggests that GLP-1 drugs could have unexpected mental health benefits, including lower risks of depression, anxiety, and substance use.

Wegovy 1.7mg injectable Pen from Novo Nordisk for the treatment of Obesity, those at risk of Diabetes and those with Type 2 Diabetes.